Skip to main content
. 2021 Jun 21;13(12):3101. doi: 10.3390/cancers13123101

Figure 5.

Figure 5

Evolution of MAF levels over followup time in patients with or without progression under treatment. Data are from a mixed model using 74 MAF measurements from 15 patients. MAF: mutant allele frequency; PFS: progression-free survival.